ConcertAI

ConcertAI is a healthcare intelligence company based in Cambridge, Massachusetts, specializing in clinical artificial intelligence and real-world data solutions, particularly in oncology research and clinical development. Founded in 2018, the company aims to enhance patient outcomes by transforming complex cancer care data into actionable insights. Its proprietary CARA platform integrates predictive and generative AI to manage and analyze unstructured healthcare information. The company offers a range of services, including real-world data products, digital trial solutions, and clinical trial optimization tools. These services help pharmaceutical companies and healthcare providers streamline clinical trials, improve patient recruitment, and gain insights into treatment efficacy. ConcertAI serves over 50 life science companies and 2,000 healthcare providers globally, reflecting its significant impact in the oncology sector. With a valuation of approximately $1.9 billion, ConcertAI is committed to advancing healthcare intelligence through innovative data solutions.